Articles & Abstracts
Targeted delivery of anticancer agents using antibodies as vectors
- Published:1. Dec 2013
- Authors:Maria Toloudi MD, Ioannis Papasotiriou MD, PhD
The contribution of antibodies to targeted cancer therapy
- Published:1. Nov 2013
- Authors:Panagiotis Apostolou, Dr. Ioannis Papasotiriou
AP-1 Gene Expression Levels May Be Correlated with Changes in Gene Expression of Some Stemness Factors in Colon Carcinomas
- Published:1. Oct 2013
- Authors:Panagiotis Apostolou, Maria Toloudi, Eleni Ioannou, Marina Chatziioannou, Eleni Kourtidou, Ioanna Vlachou, and Ioannis Papasotiriou
Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells
- Published:1. Aug 2013
- Authors:Apostolou P, Toloudi M, Ioannou E, Kourtidou E, Chatziioannou M, Kopic A, Komiotis D, Kiritsis C, Manta S, Papasotiriou I.
Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines
- Published:1. Mar 2013
- Authors:Apostolou P, Toloudi M, Chatziioannou M, Ioannou E, Knocke DR, Nester J, Komiotis D, Papasotiriou I.
The MAPK/ERK pathway among Colon Cancer Cells, Colon Cancer Stem Cells, Embryonic Stem Cells and Normal Cells
- Published:18. Oct 2013
- Authors:Apostolou P., Toloudi M., Chatziioannou M., Ioannou E., Kourtidou E., Vlachou I., Papasotiriou I.
The study of GSTP1 Ile105Val polymorphism among normal, cancer and cancer stem cells, in a wide spectrum of human tumors
- Published:18. Oct 2013
- Authors:Apostolou P., Toloudi M., Chatziioannou M., Ioannou E., Kourtidou E., Vlachou I., Papasotiriou I.
The study of gene expression as a tool for predicting response to chemotherapy in pancreatic cancer
- Published:3. Jul 2013
- Authors:Apostolou P., Toloudi M., Chatziioannou M., Ioannou E., Papasotiriou I
Is there any Correlation between the number change in circulating tumor cells and the clinical evaluation in cancer patients?
- Published:25. Apr 2013
- Authors:Chatziioannou M.1, Kyriazopouloy A. 1, Ioannou Ε.1, Toloudi Μ.1, Apostolou P.1, Hammon R.2, Hembry N.4, Jacob U.3, Kopic A.3, Papasotiriou Ι
DCs as cancer vaccines. Mature DCs as a tool to sustain minimal residual disease status in malignancies
- Published:5. Mar 2013
- Authors:E. Ioannou, M. Chatziioannou, M. Toloudi, P. Apostolou, I. Papasotiriou
Find out more about the scientific basis of RGCC tests